Um den vollen visuellen und funktionalen Umfang dieser Website genießen zu können, aktivieren sie bitte Javascript in ihrem Browser.
About us
Our Approach
Mission &
Vision
Therapeutic
Focus
About Depression
Personalized Psychiatry
Research &
Programs
Programs
Pipeline
Ketabon
Nelivabon
Our Team
Executive Team
HMNC Team
Supervisory Board
Scientific Advisory Board
Careers
News &
Publications
Newsroom
Publications
Contact
06
Pipeline
Current status of our programs
Ketabon
Oral prolonged release formulation of ketamine
Nelivabon
Vasopressin V1b antagonist & test
Modal title
×
Modal body text goes here.